What is Cadence Biomedical?
Cadence Biomedical is a specialized medical device manufacturer focused on restoring mobility for patients suffering from neurological impairments. Its core product, Kickstart, serves as a sophisticated neurorehabilitation tool designed to assist individuals recovering from stroke, spinal cord injuries, and other debilitating conditions. By providing essential stability and gait control, the device facilitates physical therapy both in clinical environments and home settings. The company's market position is bolstered by its integration into standard healthcare reimbursement frameworks, including Medicare and private insurance, which validates the clinical efficacy and economic viability of its rehabilitation technology.
How much funding has Cadence Biomedical raised?
Cadence Biomedical has raised a total of $3.3M across 3 funding rounds:
Series A
$1.1M
Private Equity
$959K
Series B
$1.2M
Series A (2012): $1.1M with participation from HealthTech Capital, Keiretsu Forum, Tech Coast Angels, Sand Hill Angels, and Alliance of Angels
Private Equity (2015): $959K, investors not publicly disclosed
Series B (2015): $1.2M supported by Frontier Angels and HealthTech Capital
Key Investors in Cadence Biomedical
Frontier Angels
A Montana-based network of accredited investors dedicated to accelerating the growth of high-potential technology startups through strategic capital and mentorship.
HealthTech Capital
A Silicon Valley-based investment organization that connects healthcare systems and angel investors to foster innovation within the digital health and medical technology sectors.
Keiretsu Forum
A global investment community of accredited private equity angel investors, venture capitalists, and corporate/institutional investors focused on early-stage and high-growth opportunities.
What's next for Cadence Biomedical?
With the recent influx of capital, Cadence Biomedical is well-positioned to accelerate its commercialization strategy and deepen its penetration into the global neurorehabilitation market. The company is expected to leverage this financing to enhance its manufacturing capabilities and expand its clinical footprint. As the demand for accessible, home-based physical therapy solutions continues to rise, Cadence Biomedical remains focused on scaling its operations to meet the needs of a growing patient demographic, while simultaneously exploring further innovations in assistive robotics to maintain its competitive edge in the healthtech landscape.
See full Cadence Biomedical company page
